Wagas, Segundina .

HRN: 28-62-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/06/2026
05/12/2026
IV
680mg
OD
Skin And Soft Tissue Infection
Checking Initial Appropriateness 

 Indication:  Culture-directed    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines